Novel Functions of the Phospholipase D2-Phox Homology Domain in Protein Kinase Cζ Activation

REFERENCES

• Banno, Y., and Y. Nozawa. 2003. Hydrogen peroxide-induced phospholipase D activation and its PKC dependence are modulated by pH changes in PC12 cells. Biochem. Biophys. Res. Commun. 312:1087–1093.
   PubMedGoogle Scholar
• Berra, E., M. T. Diaz-Meco, I. Dominguez, M. M. Municio, L. Sanz, J. Lozano, R. S. Hapkin, and J. Moscat. 1993. Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell 74:555–563.
   PubMed Web of Science ®Google Scholar
• Billah, M. M., J. K. Pai, T. J. Mullmann, R. W. Egan, and M. I. Siegel. 1989. Regulation of phospholipase D in HL-60 granulocytes. J. Biol. Chem. 264:9069–9076.
   PubMedGoogle Scholar
• Burnett, P. E., R. K. Barrow, N. A. Cohen, S. H. Snyder, and D. M. Sabatini. 1998. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. USA 95:1432–1437.
   PubMed Web of Science ®Google Scholar
• Brown, H. A., S. Gutowski, R. A. Kahn, and P. C. Sternweis. 1995. Partial purification and characterization of Arf-sensitive phospholipase D from porcine brain. J. Biol. Chem. 270:14935–14943.
   PubMedGoogle Scholar
• Chen, H. C., G. Bandyopadhyay, M. P. Sajan, Y. Kanoh, M. Standaert, R. V. Farese, Jr., and R. V. Farese. 2002. Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport. J. Biol. Chem. 277:23554–23562.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Y. Zheng, and D. A. Foster. 2003. Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene 22:3937–3942.
   PubMed Web of Science ®Google Scholar
• Chou, M. M., W. Hou, J. Johnson, L. K. Graham, M. H. Lee, C. S. Chen, A. C. Newton, B. S. Schaffhausen, and A. Toker. 1998. Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr. Biol. 8:1069–1077.
   PubMed Web of Science ®Google Scholar
• Colley, W. C., T. C. Sung, R. Roll, J. Jenco, S. M. Hammond, Y. Altshuller, D. Bar-Sagi, A. J. Morris, and M. A. Frohman. 1997. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr. Biol. 7:191–201.
   PubMed Web of Science ®Google Scholar
• Daniel, L. W., V. A. Sciorra, and S. Ghosh. 1999. Phospholipase D, tumor promoters, proliferation and prostaglandins. Biochim. Biophys. Acta 1439:265–276.
   PubMedGoogle Scholar
• Diaz-Meco, M. T., and J. Moscat. 2001. MEK5, a new target of the atypical protein kinase C isoforms in mitogenic signaling. Mol. Cell. Biol. 21:1218–1227.
   PubMedGoogle Scholar
• Du, G., P. Huang, B. T. Liang, and M. A. Frohman. 2004. Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. Mol. Biol. Cell 15:1024–1030.
   PubMed Web of Science ®Google Scholar
• Du, G., Y. M. Altshuller, N. Vitale, P. Huang, S. Chasserot-Golaz, A. J. Morris, M. F. Bader, and M. A. Frohman. 2003. Regulation of phospholipase D1 subcellular cycling through coordination of multiple membrane association motifs. J. Cell Biol. 162:305–315.
   PubMed Web of Science ®Google Scholar
• Fang, Y., M. Vilella-Bach, R. Bachmann, A. Flanigan, and J. Chen. 2001. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294:1942–1945.
   PubMed Web of Science ®Google Scholar
• Foster, D. A., and L. Xu. 2003. Phospholipase d in cell proliferation and cancer. Mol. Cancer Res. 1:789–800.
   PubMed Web of Science ®Google Scholar
• Fowler, C. A., C. M. Perks, P. V. Newcomb, P. B. Savage, J. R. Farndon, and J. M. Holly. 2000. Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cells. Int. J. Cancer 88:448–453.
   PubMed Web of Science ®Google Scholar
• Freeman, E. J., G. M. Chisolm, and E. A. Tallant. 1995. Role of calcium and protein kinase C in the activation of phospholipase D by angiotensin II in vascular smooth muscle cells. Arch. Biochem. Biophys. 319:84–92.
   PubMed Web of Science ®Google Scholar
• Freyberg, Z., D. Sweeney, A. Siddhanta, S. Bourgoin, M. A. Frohman, and D. Shields. 2001. Intracellular localization of phospholipase D1 in mammalian cells. Mol. Biol. Cell 12:943–955.
   PubMed Web of Science ®Google Scholar
• Freyberg, Z., S. Bourgoin, and D. Shields. 2002. Phospholipase D2 is localized to the rims of the Golgi apparatus in mammalian cells. Mol. Biol. Cell 13:3930–3942.
   PubMed Web of Science ®Google Scholar
• Frohman, M. A., T. C. Sung, and A. J. Morris. 1999. Mammalian phospholipase D structure and regulation. Biochim. Biophys. Acta 1439:175–186.
   PubMed Web of Science ®Google Scholar
• Ghosh, P. M., R. Bedolla, M. Mikhailova, and J. I. Kreisberg. 2002. RhoA-dependent murine prostate cancer cell proliferation and apoptosis: role of protein kinase Czeta. Cancer Res. 62:2630–2636.
   PubMed Web of Science ®Google Scholar
• Hammond, S. M., J. M. Jenco, S. Nakashima, K. Cadwallader, Q. Gu, S. Cook, Y. Nozawa, G. D. Prestwich, M. A. Frohman, and A. J. Morris. 1997. Characterization of two alternately spliced forms of phospholipase D1. J. Biol. Chem. 272:3860–3868.
   PubMed Web of Science ®Google Scholar
• Hammond, S. M., Y. M. Altshuller, T. C. Sung, S. A. Rudge, K. Rose, J. Engebrecht, A. J. Morris, and M. A. Frohman. 1995. Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J. Biol. Chem. 270:29640–29643.
   PubMed Web of Science ®Google Scholar
• Han, J. M., J. H. Kim, B. D. Lee, S. D. Lee, Y. Kim, Y. W. Jung, S. Lee, W. Cho, M. Ohba, T. Kuroki, P. G. Suh, and S. H. Ryu. 2002. Phosphorylation-dependent regulation of phospholipase D2 by protein kinase C delta in rat Pheochromocytoma PC12 cells. J. Biol. Chem. 277:8290–8297.
   PubMedGoogle Scholar
• Hodgkin, M. N., J. M. Clark, S. Rose, K. Saqib, and M. J. Wakelam. 1999. Characterization of the regulation of phospholipase D activity in the detergent-insoluble fraction of HL60 cells by protein kinase C and small G-proteins. Biochem. J. 339:87–93.
   PubMedGoogle Scholar
• Jang, I. H., S. Lee, J. B. Park, J. H. Kim, C. S. Lee, E. M. Hur, I. S. Kim, K. T. Kim, H. Yagisawa, P. G. Suh, and S. H. Ryu. 2003. The direct interaction of phospholipase C-gamma 1 with phospholipase D2 is important for epidermal growth factor signaling. J. Biol. Chem. 278:18184–18190.
   PubMedGoogle Scholar
• Jeffrey, P. D., A. A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massague, and N. P. Pavletich. 1995. Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex. Nature 376:313–320.
   PubMed Web of Science ®Google Scholar
• Joberty, G., C. Petersen, L. Gao, and I. G. Macara. 2000. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat. Cell Biol. 2:531–539.
   PubMed Web of Science ®Google Scholar
• Kim, J. H., S. D. Lee, J. M. Han, T. G. Lee, Y. Kim, J. B. Park, J. D. Lambeth, P. G. Suh, and S. H. Ryu. 1998. Activation of phospholipase D1 by direct interaction with ADP-ribosylation factor 1 and RalA. FEBS Lett. 430:231–235.
   PubMed Web of Science ®Google Scholar
• Kim, J. H., S. Lee, J. H. Kim, T. G. Lee, M. Hirata, P. G. Suh, and S. H. Ryu. 2002. Phospholipase D2 directly interacts with aldolase via its PH domain. Biochemistry 41:3414–3421.
   PubMedGoogle Scholar
• Kim, J. H., Y. Kim, S. D. Lee, I. Lopez, R. S. Arnold, J. D. Lambeth, P. S. Suh, and S. H. Ryu. 1999. Selective activation of phospholipase D2 by unsaturated fatty acid. FEBS Lett. 454:42–46.
   PubMedGoogle Scholar
• Kim, Y., J. M. Han, B. R. Han, K. A. Lee, J. H. Kim, B. D. Lee, I. H. Jang, P. G. Suh, and S. H. Ryu. 2000. Phospholipase D1 is phosphorylated and activated by protein kinase C in caveolin-enriched microdomains within the plasma membrane. J. Biol. Chem. 275:13621–13627.
   PubMed Web of Science ®Google Scholar
• Lee, H. Y., J. B. Park, I. H. Jang, Y. C. Chae, J. H. Kim, I. S. Kim, P. G. Suh, and S. H. Ryu. 2004. Munc-18-1 inhibits phospholipase D activity by direct interaction in an epidermal growth factor-reversible manner. J. Biol. Chem. 279:16339–16348.
   PubMedGoogle Scholar
• Lee, S., J. B. Park, J. H. Kim, Y. Kim, J. H. Kim, K. J. Shin, J. S. Lee, S. H. Ha, P. G. Suh, and S. H. Ryu. 2001. Actin directly interacts with phospholipase D, inhibiting its activity. J. Biol. Chem. 276:28252–28260.
   PubMed Web of Science ®Google Scholar
• Lee, S., J. H. Kim, C. S. Lee, J. H. Kim, Y. Kim, K. Heo, Y. Ihara, Y. Goshima, P. G. Suh, and S. H. Ryu. 2002. Collapsin response mediator protein-2 inhibits neuronal phospholipase D(2) activity by direct interaction. J. Biol. Chem. 277:6542–6549.
   PubMedGoogle Scholar
• Lee, S. D., B. D. Lee, J. M. Han, J. H. Kim, Y. Kim, P. G. Suh, and S. H. Ryu. 2000. Phospholipase D2 activity suppresses hydrogen peroxide-induced apoptosis in PC12 cells. J. Neurochem. 75:1053–1059.
   PubMed Web of Science ®Google Scholar
• Lee, S. D., B. D. Lee, Y. Kim, P. G. Suh, and S. H. Ryu. 2000. Bradykinin activates phospholipase D2 via protein kinase cdelta in PC12 cells. Neurosci. Lett. 294:130–132.
   PubMedGoogle Scholar
• Le Good, J. A., W. H. Ziegler, D. B. Parekh, D. R. Alessi, P. Cohen, and P. J. Parker. 1998. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281:2042–2045.
   PubMed Web of Science ®Google Scholar
• Lin, D., A. S. Edwards, J. P. Fawcett, G. Mbamalu, J. D. Scott, and T. Pawson. 2000. A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC signaling and cell polarity. Nat. Cell Biol. 2:540–547.
   PubMedGoogle Scholar
• Lu, Y., L. Jamieson, A. R. Brasier, and A. P. Fields. 2001. NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival. Oncogene 20:4777–4792.
   PubMedGoogle Scholar
• Mao, M., X. Fang, Y. Lu, R. Lapushin, R. C. Bast, Jr., and G. B. Mills. 2000. Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells. Biochem. J. 352:475–482.
   PubMedGoogle Scholar
• Mellor, H., and P. J. Parker. 1998. The extended protein kinase C superfamily. Biochem. J. 332:281–292.
   PubMed Web of Science ®Google Scholar
• Michael, I., Wilson, D. J. Gill, O. Perisic, M. T. Quinn, and R. L. Williams. 2003. PB1 domain-mediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62. Mol. Cell 12:39–50.
   PubMedGoogle Scholar
• Murray, N. R., and A. P. Fields. 1997. Atypical protein kinase C iota protects human leukemia cells against drug-induced apoptosis. J. Biol. Chem. 272:27521–27524.
   PubMed Web of Science ®Google Scholar
• Mwanjewe, J., M. Spitaler, M. Ebner, M. Windegger, M. Geiger, S. Kampfer, J. Hofmann, F. Uberall, and H. H. Grunicke. 2001. Regulation of phospholipase D isoenzymes by transforming Ras and atypical protein kinase C-iota. Biochem. J. 359:211–217.
   PubMedGoogle Scholar
• Newton, A. C. 2001. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 101:2353–2364.
   PubMed Web of Science ®Google Scholar
• Newton, A. C. 2003. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem. J. 370:361–371.
   PubMed Web of Science ®Google Scholar
• Noh, D. Y., S. J. Ahn, R. A. Lee, I. A. Park, J. H. Kim, P. G. Suh, S. H. Ryu, K. H. Lee, and J. S. Han. 2000. Overexpression of phospholipase D1 in human breast cancer tissues. Cancer Lett. 161:207–214.
   PubMed Web of Science ®Google Scholar
• Ohguchi, K., Y. Banno, S. Nakashima, and Y. Nozawa. 1996. Regulation of membrane-bound phospholipase D by protein kinase C in HL60 cells. Synergistic action of small GTP-binding protein RhoA. J. Biol. Chem. 271:4366–4372.
   PubMedGoogle Scholar
• Park, J. B., J. H. Kim, Y. Kim, S. H. Ha, J. S. Yoo, G. Du, M. A. Frohman, P. S. Suh, and S. H. Ryu. 2000. Cardiac phospholipase D2 localizes to sarcolemmal membranes and is inhibited by alpha-actinin in an ADP-ribosylation factor-reversible manner. J. Biol. Chem. 275:21295–21301.
   PubMedGoogle Scholar
• Parmentier, J. H., P. Smelcer, Z. Pavicevic, E. Basic, A. Idrizovic, A. Estes, and K. U. Malik. 2003. PKC-zeta mediates norepinephrine-induced phospholipase D activation and cell proliferation in VSMC. Hypertension 41:794–800.
   PubMed Web of Science ®Google Scholar
• Plant, P. J., J. P. Fawcett, D. C. Lin, A. D. Holdorf, K. Binns, S. Kulkarni, and T. Pawson. 2003. A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl. Nat. Cell Biol. 5:301–308.
   PubMed Web of Science ®Google Scholar
• Puls, A., S. Schmidt, F. Grawe, and S. Stabel. 1997. Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein. Proc. Natl. Acad. Sci. USA 94:6191–6196.
   PubMed Web of Science ®Google Scholar
• Romanelli, A., K. A. Martin, A. Toker, and J. Blenis. 1999. p70 S6 kinase is regulated by protein kinase Cζ and participates in a phosphoinositide 3-kinase-regulated signalling complex. Mol. Cell. Biol. 19:2921–2928.
   PubMed Web of Science ®Google Scholar
• Russo, A. A., P. D. Jeffrey, and N. P. Pavletich. 1996. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat. Struct. Biol. 3:696–700.
   PubMedGoogle Scholar
• Sanchez, P., G. De Carcer, I. V. Sandoval, J. Moscat, and M. T. Diaz-Meco. 1998. Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Mol. Cell. Biol. 18:3069–3080.
   PubMed Web of Science ®Google Scholar
• Shome, K., Y. Nie, and G. Romero. 1998. ADP-ribosylation factor proteins mediate agonist-induced activation of phospholipase D. J. Biol. Chem. 273:30836–30841.
   PubMed Web of Science ®Google Scholar
• Singer, W. D., H. A. Brown, X. Jiang, and P. C. Sternweis. 1996. Regulation of phospholipase D by protein kinase C is synergistic with ADP-ribosylation factor and independent of protein kinase activity. J. Biol. Chem. 271:4504–4510.
   PubMed Web of Science ®Google Scholar
• Standaert, M. L., G. Bandyopadhyay, Y. Kanoh, M. P. Sajan, and R. V. Farese. 2001. Insulin and PIP3 activate PKC-zeta by mechanisms that are both dependent and independent of phosphorylation of activation-loop (T410) and autophosphorylation (T560) sites. Biochemistry 40:249–255.
   PubMedGoogle Scholar
• Sung, T. C., Y. M. Altshuller, A. J. Morris, and M. A. Frohman. 1999. Molecular analysis of mammalian phospholipase D2. J. Biol. Chem. 274:494–502.
   PubMed Web of Science ®Google Scholar
• Toker, A., and A. C. Newton. 2000. Cellular signaling: pivoting around PDK-1. Cell 103:185–188.
   PubMed Web of Science ®Google Scholar
• Uchida, N., S. Okamura, and H. Kuwano. 1999. Phospholipase D activity in human gastric carcinoma. Anticancer Res. 19:671–675.
   PubMed Web of Science ®Google Scholar
• Uchida, N., S. Okamura, Y. Nagamachi, and S. Yamashitam. 1997. Increased phospholipase D activity in human breast cancer. J. Cancer Res. Clin. Oncol. 123:280–285.
   PubMed Web of Science ®Google Scholar
• Yang, J., P. Cron, V. Thompson, V. M. Good, D. Hess, B. A. Hemmings, and D. Barford. 2002. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell 9:1227–1240.
   PubMed Web of Science ®Google Scholar
• Zhao, Y., H. Ehara, Y. Akao, M. Shamoto, Y. Nakagawa, Y. Banno, T. Deguchi, N. Ohishi, K. Yagi, and Y. Nozawa. 2000. Increased activity and intranuclear expression of phospholipase D2 in human renal cancer. Biochem. Biophys. Res. Commun. 278:140–143.
   PubMed Web of Science ®Google Scholar